Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Growth hormone therapy will improve the height of idiopathic short statured children. DA-3002(Recombinant Human Growth hormone)treated group for 26 weeks, will be compared to non-treatment group in efficacy and safety.
Epistemonikos ID: b2caeaf9079d28bff5b767f5e86fbd40512fa79a
First added on: May 11, 2024